Citations

Clear

1825 citation(s) found for "Yu, Emily".

Antisynthetase Syndrome with Severe Interstitial Lung Disease in Pregnancy
Dumitrascu, Catalina I. , Olsen, David A. , Arendt, Katherine W. , Rose, Carl H., Sharpe, Emily E. , Sharpe, Emily E

Mayo Clinic

Case Reports in Anesthesiology | July 26, 2021 | Volume: 2021 | Issue: No issue available | Pages: 1-4

10.1155/2021/1150394 | PMID 34350037 Get It

Antisynthetase syndrome is a rare multisystem autoimmune disorder which clinically manifests with myositis, arthritis, interstitial lung disease, Raynaud phenomenon, and skin hyperkeratosis. Lung involvement represents the most severe form of disease and has rarely been reported in pregnancy. We present the case of a 22-year-old woman with antisynthetase syndrome and severe restrictive pulmonary disease who experienced a successful pregnancy and delivery. We discuss anesthetic considerations and highlight the importance of a multidisciplinary team approach in caring for parturients with multifactorial medical conditions.
Non‐motor phenotypic subgroups in adult‐onset idiopathic, isolated, focal cervical dystonia
Wadon, Megan E. , Bailey, Grace , Yılmaz, Zehra, Hubbard, Emily , Alsaeed, Meshari , McLauchlan, Duncan , Barbano, Richard L. , Marsh, Laura , Fox, Susan H. , Rodriguez, Ramon L. , Comella, Cynthia , Reich, Stephen G. , Severt, William, Robinson, Amy, Factor, Stewart Alan , Adler, Charles H. , Goetz, Christopher G. , Perlmutter, Joel S. , Jinnah, H. A. , Harding, Katharine E , Sandor, Cynthia , Peall, Kathryn J.

Mayo Clinic

Brain and Behavior | July 21, 2021 | Volume: 11 | Issue: 8 | Pages: No page available

10.1002/brb3.2292 | PMID 34291595 Get It

Abstract Background : Non‐motor symptoms are well established phenotypic components of adult‐onset idiopathic, isolated, focal cervical dystonia (AOIFCD). However, improved understanding of their clinical heterogeneity is needed to better target therapeutic intervention. Here, we examine non‐motor phenotypic features to identify possible AOIFCD subgroups. Methods : Participants diagnosed with AOIFCD were recruited via specialist neurology clinics (dystonia wales: n = 114, dystonia coalition: n = 183). Non‐motor assessment included psychiatric symptoms, pain, sleep disturbance, and quality of life, assessed using self‐completed questionnaires or face‐to‐face assessment. Both cohorts were analyzed independently using Cluster, and Bayesian multiple mixed model phenotype analyses to investigate the relationship between non‐motor symptoms and determine evidence of phenotypic subgroups. Results : Independent cluster analysis of the two cohorts suggests two predominant phenotypic subgroups, one consisting of approximately a third of participants in both cohorts, experiencing increased levels of depression, anxiety, sleep impairment, and pain catastrophizing, as well as, decreased quality of life. The Bayesian approach reinforced this with the primary axis, which explained the majority of the variance, in each cohort being associated with psychiatric symptomology, and also sleep impairment and pain catastrophizing in the Dystonia Wales cohort. Conclusions : Non‐motor symptoms accompanying AOIFCD parse into two predominant phenotypic sub‐groups, with differences in psychiatric symptoms, pain catastrophizing, sleep quality, and quality of life. Improved understanding of these symptom groups will enable better targeted pathophysiological investigation and future therapeutic intervention.
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2
Drayman, Nir , DeMarco, Jennifer K. , Jones, Krysten A. , Azizi, Saara‐Anne , Froggatt, Heather M. , Tan, Kemin , Maltseva, N. , Chen, Siquan, Nicolaescu, Vlad , Dvorkin, Steve, Furlong, Kevin, Firpo, Mason R. , Mastrodomenico, Vincent , Bruce, Emily A. , Schmidt, Madaline M. , Jedrzejczak, R. , Schuster, Brooke , Nair, Vishnu , Han, Kyu‐Yeon , O’Brien, Amornrat , Τοματσίδου, Αναστασία, Vignuzzi, Marco , Botten, Jason , Brooke, Christopher B. , Lee, Hyun , Severson, William E., Palmer, Kenneth E. , Dickinson, Bryan C. , Joachimiak, A. , Randall, Glenn , Tay, Savaş , Maltseva, Natalia Ivanovna , Kathayat, Rahul S , Bruce, Emily A , Schmidt, Madaline M , Jedrzejczak, Robert , Muñoz-Alía, Miguel Á , Schuster, Brooke , Nair, Vishnu , Han, Kyu-Yeon , Meyer, Bjoern , Vignuzzi, Marco , Botten, Jason W , Brooke, Christopher B , Lee, Hyun , Baker, Susan C , Mounce, Bryan C , Heaton, Nicholas S , Dickinson, Bryan C , Joachimiak, Andrzej , Randall, Glenn , Tay, Savaş , Furlong, Kevin, Muñoz-Alía, Miguel Ángel , Missiakas, Dominique M.

Mayo Clinic

Science | July 20, 2021 | Volume: 373 | Issue: 6557 | Pages: 931-936

10.1126/science.abg5827 | PMID 34285133 Get It

Targeting the main protease of SARS-CoV-2 Inside host cells, the RNA genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is translated into two polyproteins that are cleaved to give the individual viral proteins. The main viral protease, known as Mpro or 3CLpro, plays a key role in these cleavages, making it an important drug target. Drayman et al . identified eight drugs that target 3CLpro from a library of 1900 clinically safe drugs. Because of the challenge of working with SARS-CoV-2, they started by screening for drugs that inhibit the replication of a human coronavirus that causes the common cold. They then evaluated the top hits for inhibiting SARS-CoV-2 replication and for inhibiting 3CLpro. Masitinib, a broad antiviral, inhibited the main proteases of coronaviruses and picornaviruses and was effective in reducing SARS-CoV-2 replication in mice. —VV
Timing of Flap Coverage With Respect to Definitive Fixation in Open Tibia Fractures
Kuripla, Casey, Foote, Clary J. , Koh, Justin , Sems, Andrew, Shamaa, Tayseer , Sorg, Debra, Streufert, Benjamin D. , Spitler, Clay A. , McGowan, Brian, Weinlein, John C., Cannada, Lisa K. , Charlu, Jonathan, Wagstrom, Emily, Westberg, Jerald R., Cortez, Abigail , Marcantonio, Andrew , Soles, Gillian , Lipof, Jason S. , Tornetta, Paul , Sems, Andrew, Vallier, Heather A. , Mir, Hassan R. , Mullis, Brian , Morshed, Saam , Krause, Peter C.

Mayo Clinic

Journal of Orthopaedic Trauma | July 16, 2021 | Volume: 35 | Issue: 8 | Pages: 430-436

10.1097/bot.0000000000002033 | PMID 34267149 Get It

Objectives: We conducted a large, U.S wide, observational study of type III tibial fractures, with the hypothesis that delays between definitive fixation and flap coverage might be a substantial modifiable risk factor associated with nosocomial wound infection. Design: A retrospective analysis of a multicenter database of open tibial fractures requiring flap coverage. Setting: Fourteen level-1 trauma centers across the United States. Patients: Two hundred ninety-six (n = 296) consecutive patients with Gustilo III open tibial fractures requiring flap coverage at 14 trauma centers were retrospectively analyzed from a large orthopaedic trauma registry. We collected demographics and the details of surgical care. We investigated the patient, and treatment factors leading to infection, including the time from various points in care to the time of soft-tissue coverage. Intervention: Delay definitive fixation and flap coverage in tibial type III fractures. Main Outcome Measurements: (1) Results of multivariate regression with time from injury to coverage, debridement to coverage, and definitive fixation to coverage in the model, to determine which delay measurement was most associated with infection. (2) A second multivariate model, including other factors in addition to measures of flap delay, to provide the estimate between delay and infection after adjustment for confounding. Results: Of 296 adults (227 M: 69 F) with open Gustilo type III tibial fractures requiring flap coverage, 96 (32.4%) became infected. In the multivariate regression, the time from definitive fixation to flap coverage was most predictive of subsequent wound infection (odds ratio 1.04, 95% confidence interval 1.01 to 1.08, n = 260, P = 0.02) among the time measurements. Temporary internal fixation was not associated with an increased risk of infection in both univariate (P = 0.59) or multivariate analyses (P = 0.60). Flap failure was associated with the highest odds of infection (odds ratio 6.83, 95% confidence interval 3.26 to 14.27, P < 0.001). Conclusion: Orthoplastic teams that are dedicated to severe musculoskeletal trauma, that facilitate coordination of definitive fixation and flap coverage, will reduce the infection rates in Gustilo type III tibial fractures. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
Iatrogenic Third Window After Retrosigmoid Approach to a Vestibular Schwannoma Managed with Cochlear Implantation
Deep, Nicholas L. , Kay‐Rivest, Emily , Roland, J. Thomas

Mayo Clinic

Otology & Neurotology | July 15, 2021 | Volume: 42 | Issue: 9 | Pages: 1355-1359

10.1097/mao.0000000000003267 | PMID 34267100 Get It

Objective: To present a case of an iatrogenic inner ear third window after vestibular schwannoma microsurgery. Patients: A 42-year-old male presented 9-months after left-sided retrosigmoid approach for an intracanalicular vestibular schwannoma with hearing-preservation attempt performed elsewhere. Immediately postoperatively, he developed the following disabling and persistent symptoms on the ipsilateral side: autophony, pulsatile tinnitus, high-pitched ringing tinnitus, and hearing his footsteps. He denied vertigo. Otoscopy was normal. Tuning fork (512-Hz) lateralized to the left and Rinne was negative on the left. Audiogram demonstrated a severe mixed hearing loss and 10% aided word-recognition score. High-resolution CT demonstrated violation of the common crus and dehiscence of bone along the medial vestibule suggestive of an iatrogenic inner ear third window. Interventions: Labyrinthectomy and concurrent cochlear implantation. Main outcome measures: Resolution of third window symptoms, open-set speech recognition, tinnitus suppression. Results: Patient reported immediate resolution of third window symptoms after labyrinthectomy and cochlear implantation. He demonstrates open-set word recognition of 64% at 1-year postoperatively and tinnitus suppression with his cochlear implant on. Conclusions: Iatrogenic third window symptoms can occur after hearing-preservation vestibular schwannoma microsurgery. Patients with sufficient hearing preservation who are disabled by third window symptoms yet lack sound clarity and useful hearing may be considered for labyrinthectomy and concurrent cochlear implantation. This intervention effectively extinguishes third window symptoms by destroying residual auditory function and simultaneously provides an opportunity to restore useful hearing and suppress tinnitus, thereby enhancing overall quality of life.
Functional status in postural tachycardia syndrome
Rich, Emily , Vas, Asha , Krone, Ryan, Goodman, Brent P., Rich, Emily M , Parsons, Thomas D.

Mayo Clinic

British Journal of Occupational Therapy | July 15, 2021 | Volume: 85 | Issue: 6 | Pages: 418-426

10.1177/03080226211031807 | PMID 40336664 Get It

Introduction Postural tachycardia syndrome is a form of orthostatic intolerance that often leads to functional impairment. Methods This survey explored functional status and impact of symptoms in adults ( n = 958) ages 18 to 60 (M = 32.63 ± 10.52 years, 96.7% female) with postural tachycardia syndrome. Results Individuals reported an average of 11 daily life activities impacted by postural tachycardia syndrome with high levels of self-perceived disability. Additionally, 93.4% reported some degree of cognitive impairment and falls occurred in 55.3% of participants annually. Despite frequent falls and functional impairment, participants infrequently (26.9%) utilized therapy services. Conclusion Individuals with postural tachycardia syndrome are at an increased risk of experiencing disability and often require assistance with daily activities. Further research is necessary to understand the potential role of therapy in improving function and quality of life.
Coronavirus disease 2019 in children
Levy, Emily R. , Blumenthal, Jennifer , Levy, Emily R , Chiotos, Kathleen

Mayo Clinic

Current Opinion in Infectious Diseases | July 15, 2021 | Volume: 34 | Issue: 5 | Pages: 500-509

10.1097/qco.0000000000000762 | PMID 34261902 Get It

Purpose of review Over the course of the coronavirus disease 2019 (COVID-19) pandemic, it has become clear that the clinical features, epidemiology, and outcomes of COVID-19 are distinct in children relative to adults. In this review, we will present recent pediatric studies informing our current understanding of COVID-19 in children, and review pediatric considerations surrounding disease transmission, currently available therapies, and vaccination. Recent findings Recent studies have shed light on the clinical epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children, identifying a high prevalence of asymptomatic and mild infections, with severe COVID-19 infrequently reported. Several adult clinical trials have informed the use of remdesivir, anti-SARS-CoV-2 monoclonal antibodies, dexamethasone, and tocilizumab in the management of COVID-19. Associations between underlying comorbid medical conditions and severe outcomes, as well as transmission dynamics of SARS-CoV-2 in children, are complex and warrant further study. Finally, highly efficacious vaccines are available for adults and adolescents, with pediatric trials ongoing. Summary Children generally fare well with acute COVID-19 infection, though critical illness is possible. Future research should focus on clarifying the role of children in SARS-CoV-2 transmission and optimal prevention strategies, particularly in the school setting, as well as evaluating pediatric vaccine candidates.
Surgical Reduction of Spondylolisthesis During Lumbar Fusion
Barber, Joshua A, Smith, Caleb J. , Li, Jinpu , Goldstein, Christina L, Leary, Emily , Lambrechts, Mark James , Barber, Joshua A, Beckett, Nathan , Goldstein, Christina L, Cook, James L. , Choma, Theodore J.

Mayo Clinic

Clinical Spine Surgery | July 7, 2021 | Volume: 35 | Issue: 1 | Pages: E1-E6

10.1097/bsd.0000000000001230 | PMID 34232155 Get It

Study Design: This was a retrospective cohort study. Objective: The objective of this study was to quantify the rates of complication following surgical treatment for symptomatic degenerative and isthmic spondylolisthesis and to examine the association between slip reduction and complication rates. Summary of Background Data: It is unclear if the degree of spondylolisthesis reduction during lumbar spine fusion in adults influences the rate of surgical complications. Methods: This is a retrospective cohort study of 1-level and 2-level adult fusion patients with degenerative or isthmic spondylolisthesis. The degree of reduction and complications were calculated, and complication rates between those with and without reduction were compared. Results: The surgical reduction was improved by 1 Meyerding grade in 56.5% of the 140 patients included in this analysis. Of those patients, 60% had a grade 1 spondylolisthesis. In addition, 62.5% of grade 2 slips had an improvement by 1 grade. Surgical reduction during lumbar fusion did not result in a higher rate of complications compared with in situ fusion. Conclusions: During 1-level or 2-level lumbar fusion for degenerative or isthmic spondylolisthesis, a 1-grade reduction of the slip was achieved in 56% of patients in this retrospective case series. Reduction of the spondylolisthesis was not associated with a higher rate of complication when compared with in situ fusion. Level of Evidence: Level IV.
Clinical Experience of Continuous Glucose Monitoring in Pregnancy
O’Malley, Grenye , Rosenn, Barak, Nosova, Emily , Kudva, Yogish C. , Shchur, Sophia Scarpelli, Levister, Camilla, Kaur, Ravinder Jeet , Pinsker, Jordan E. , Castorino, Kristin , Church, Mei Mei , Dassau, Eyal , Nosova, Emily V , Kaur, Ravinder, Levy, Carol J , Levy, Carol J.

Mayo Clinic

Journal of Diabetes Science and Technology | July 3, 2021 | Volume: 15 | Issue: 6 | Pages: 1402-1403

10.1177/19322968211024668 | PMID 34218719 Get It